(AI) C3 Ai - Overview
Stock: AI Platform, CRM, Health, Finance, Supply Chain
| Risk 5d forecast | |
|---|---|
| Volatility | 72.3% |
| Relative Tail Risk | -11.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.99 |
| Alpha | -92.68 |
| Character TTM | |
|---|---|
| Beta | 2.018 |
| Beta Downside | 1.979 |
| Drawdowns 3y | |
|---|---|
| Max DD | 82.86% |
| CAGR/Max DD | -0.31 |
EPS (Earnings per Share)
Revenue
Risks
Description: AI C3 Ai March 05, 2026
C3.ai, Inc. provides enterprise artificial intelligence (AI) software. Its offerings include the C3 Agentic AI Platform for application development and deployment, and various AI application suites. These suites address specific industry needs such as customer relationship management (CRM), healthcare, financial services, asset performance, supply chain, and sustainability. The company also develops AI solutions for defense, intelligence, and government sectors. Its business model focuses on subscription-based software-as-a-service (SaaS) offerings, a common model in the software industry.
C3.ai maintains strategic partnerships with major cloud providers and consulting firms to expand its market reach and integrate its AI solutions. These collaborations are typical for enterprise software companies seeking to leverage existing infrastructure and client relationships. For further insights into C3.ais financial performance and market position, consider exploring its profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 1.0
| Net Income: -434.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.14 > 0.02 and ΔFCF/TA -10.77 > 1.0 |
| NWC/Revenue: 215.9% < 20% (prev 216.1%; Δ -0.15% < -1%) |
| CFO/TA -0.14 > 3% & CFO -125.6m > Net Income -434.5m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 6.58 > 1.5 & < 3 |
| Outstanding Shares: last quarter (138.7m) vs 12m ago 6.36% < -2% |
| Gross Margin: 43.45% > 18% (prev 0.60%; Δ 4285 % > 0.5%) |
| Asset Turnover: 31.51% > 50% (prev 34.77%; Δ -3.26% > 0%) |
| Interest Coverage Ratio: -3.56 > 6 (EBITDA TTM -436.2m / Interest Expense TTM 95.1m) |
Altman Z'' -14.10
| A: 0.74 (Total Current Assets 782.7m - Total Current Liabilities 118.9m) / Total Assets 895.8m |
| B: -1.94 (Retained Earnings -1.73b / Total Assets 895.8m) |
| C: -0.35 (EBIT TTM -338.6m / Avg Total Assets 975.5m) |
| D: -9.83 (Book Value of Equity -1.73b / Total Liabilities 176.3m) |
| Altman-Z'' Score: -14.10 = D |
Beneish M -3.20
| DSRI: 0.82 (Receivables 123.6m/180.4m, Revenue 307.4m/366.9m) |
| GMI: 1.38 (GM 43.45% / 59.95%) |
| AQI: 1.18 (AQ_t 0.05 / AQ_t-1 0.04) |
| SGI: 0.84 (Revenue 307.4m / 366.9m) |
| TATA: -0.34 (NI -434.5m - CFO -125.6m) / TA 895.8m) |
| Beneish M-Score: -3.20 (Cap -4..+1) = AA |
What is the price of AI shares?
Over the past week, the price has changed by +11.79%, over one month by -7.49%, over three months by -37.73% and over the past year by -58.52%.
Is AI a buy, sell or hold?
- StrongBuy: 3
- Buy: 1
- Hold: 6
- Sell: 2
- StrongSell: 3
What are the forecasts/targets for the AI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9.5 | 0.6% |
| Analysts Target Price | 9.5 | 0.6% |
AI Fundamental Data Overview March 05, 2026
P/B = 1.5773
Revenue TTM = 307.4m USD
EBIT TTM = -338.6m USD
EBITDA TTM = -436.2m USD
Long Term Debt = 4.79m USD (from capitalLeaseObligations, last fiscal year)
Short Term Debt = 4.79m USD (from shortTermDebt, last fiscal year)
Debt = 4.79m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -88.8m USD (from netDebt column, last quarter)
Enterprise Value = 663.7m USD (1.28b + Debt 4.79m - CCE 621.9m)
Interest Coverage Ratio = -3.56 (Ebit TTM -338.6m / Interest Expense TTM 95.1m)
EV/FCF = -5.22x (Enterprise Value 663.7m / FCF TTM -127.0m)
FCF Yield = -19.14% (FCF TTM -127.0m / Enterprise Value 663.7m)
FCF Margin = -41.33% (FCF TTM -127.0m / Revenue TTM 307.4m)
Net Margin = -141.4% (Net Income TTM -434.5m / Revenue TTM 307.4m)
Gross Margin = 43.45% ((Revenue TTM 307.4m - Cost of Revenue TTM 173.8m) / Revenue TTM)
Gross Margin QoQ = 17.34% (prev 40.43%)
Tobins Q-Ratio = 0.74 (Enterprise Value 663.7m / Total Assets 895.8m)
Interest Expense / Debt = 177.6% (Interest Expense 8.51m / Debt 4.79m)
Taxrate = 21.0% (US default 21%)
NOPAT = -267.5m (EBIT -338.6m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 6.58 (Total Current Assets 782.7m / Total Current Liabilities 118.9m)
Debt / Equity = 0.01 (Debt 4.79m / totalStockholderEquity, last quarter 719.5m)
Debt / EBITDA = 0.20 (negative EBITDA) (Net Debt -88.8m / EBITDA -436.2m)
Debt / FCF = 0.70 (negative FCF - burning cash) (Net Debt -88.8m / FCF TTM -127.0m)
Total Stockholder Equity = 782.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -44.54% (Net Income -434.5m / Total Assets 895.8m)
RoE = -55.55% (Net Income TTM -434.5m / Total Stockholder Equity 782.1m)
RoCE = -43.03% (EBIT -338.6m / Capital Employed (Equity 782.1m + L.T.Debt 4.79m))
RoIC = -33.31% (negative operating profit) (NOPAT -267.5m / Invested Capital 803.0m)
WACC = 13.30% (E(1.28b)/V(1.29b) * Re(13.35%) + (debt cost/tax rate unavailable))
Discount Rate = 13.35% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.14%
[DCF] Fair Price = unknown (Cash Flow -127.0m)
EPS Correlation: -52.25 | EPS CAGR: -66.35% | SUE: -1.69 | # QB: 0
Revenue Correlation: 25.83 | Revenue CAGR: -7.83% | SUE: -2.51 | # QB: 0
EPS next Quarter (2026-07-31): EPS=-0.28 | Chg7d=-0.030 | Chg30d=-0.030 | Revisions Net=-3 | Analysts=13
EPS next Year (2027-04-30): EPS=-0.85 | Chg7d=+0.096 | Chg30d=+0.104 | Revisions Net=+7 | Growth EPS=+39.1% | Growth Revenue=-7.0%
[Analyst] Revisions Ratio: -0.27 (4 Up / 7 Down within 30d for Next Quarter)